Core First Bank & Trust Takeda Pharmaceutical CO LTD Transaction History

Core First Bank & Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$12.42 - $15.62 $6,247 - $7,856	-503 Reduced 71.25%	203 $3,000
Q3 2022 Nov 16, 2022	SELL	$12.8 - $28.65 $2,432 - $5,443	-190 Reduced 21.21%	706 $9,000
Q2 2022 Aug 16, 2022	SELL	$13.12 - $15.03 $110,864 - $127,003	-8,450 Reduced 90.41%	896 $13,000
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $68,019 - $72,025	4,173 Added 80.67%	9,346 $154,000
Q4 2020 Feb 16, 2021	BUY	$15.39 - $18.97 $79,612 - $98,131	5,173 New	5,173 $94,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Core First Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Core First Bank & Trust with notifications on news.